BACKGROUND AND PURPOSE: Transient receptor potential (TRP) channels are a superfamily of non-selective cation permeable channels involved in peripheral sensory signalling. Animal studies have shown that several TRPs are important players in pain modulation. Among them, the TRP melastatin 8 (TRPM8) has elicited more interest for its controversial role in nociception. This channel, expressed by a subpopulation of sensory neurons in dorsal root ganglia (DRG) and trigeminal ganglia (TG), is activated by cold temperatures and cooling agents. In experimental neuropathic pain models, an up-regulation of this receptor in DRG and TG has been observed, suggesting a key role for TRPM8 in the development and maintenance of pain. Consistent with this hypothesis, TRPM8 knockout mice are less responsive to pain stimuli. EXPERIMENTAL APPROACH: In this study, the therapeutic potential and efficacy of two novel TRPM8 antagonists, DFL23693 and DFL23448, were tested. KEY RESULTS: Two potent and selective TRPM8 antagonists with distinct pharmacokinetic profiles, DFL23693 and DFL23448, have been fully characterized in vitro. In vivo studies in well-established models, namely, the wet-dog shaking test and changes in body temperature, confirmed their ability to block the TRPM8 channel. Finally, TRPM8 blockage resulted in a significant antinociceptive effect in formalin-induced orofacial pain and in chronic constriction injury-induced neuropathic pain, confirming an important role for this channel in pain perception. CONCLUSION AND IMPLICATIONS: Our findings, in agreement with previous literature, encourage further studies for a better comprehension of the therapeutic potential of TRPM8 blockers as novel agents for pain management.
BACKGROUND AND PURPOSE: Transient receptor potential (TRP) channels are a superfamily of non-selective cation permeable channels involved in peripheral sensory signalling. Animal studies have shown that several TRPs are important players in pain modulation. Among them, the TRP melastatin 8 (TRPM8) has elicited more interest for its controversial role in nociception. This channel, expressed by a subpopulation of sensory neurons in dorsal root ganglia (DRG) and trigeminal ganglia (TG), is activated by cold temperatures and cooling agents. In experimental neuropathic pain models, an up-regulation of this receptor in DRG and TG has been observed, suggesting a key role for TRPM8 in the development and maintenance of pain. Consistent with this hypothesis, TRPM8 knockout mice are less responsive to pain stimuli. EXPERIMENTAL APPROACH: In this study, the therapeutic potential and efficacy of two novel TRPM8 antagonists, DFL23693 and DFL23448, were tested. KEY RESULTS: Two potent and selective TRPM8 antagonists with distinct pharmacokinetic profiles, DFL23693 and DFL23448, have been fully characterized in vitro. In vivo studies in well-established models, namely, the wet-dog shaking test and changes in body temperature, confirmed their ability to block the TRPM8 channel. Finally, TRPM8 blockage resulted in a significant antinociceptive effect in formalin-induced orofacial pain and in chronic constriction injury-induced neuropathic pain, confirming an important role for this channel in pain perception. CONCLUSION AND IMPLICATIONS: Our findings, in agreement with previous literature, encourage further studies for a better comprehension of the therapeutic potential of TRPM8 blockers as novel agents for pain management.
Authors: Daniel J Parks; William H Parsons; Raymond W Colburn; Sanath K Meegalla; Shelley K Ballentine; Carl R Illig; Ning Qin; Yi Liu; Tasha L Hutchinson; Mary Lou Lubin; Dennis J Stone; Judith F Baker; Craig R Schneider; Jianya Ma; Bruce P Damiano; Christopher M Flores; Mark R Player Journal: J Med Chem Date: 2010-12-03 Impact factor: 7.446
Authors: Andrea M Peier; Aziz Moqrich; Anne C Hergarden; Alison J Reeve; David A Andersson; Gina M Story; Taryn J Earley; Ilaria Dragoni; Peter McIntyre; Stuart Bevan; Ardem Patapoutian Journal: Cell Date: 2002-03-08 Impact factor: 41.582
Authors: Raymond W Colburn; Mary Lou Lubin; Dennis J Stone; Yan Wang; Danielle Lawrence; Michael R D'Andrea; Michael R Brandt; Yi Liu; Christopher M Flores; Ning Qin Journal: Neuron Date: 2007-05-03 Impact factor: 17.173
Authors: Ryan Patel; Leonor Gonçalves; Robert Newman; Feng Li Jiang; Anne Goldby; Jennifer Reeve; Alan Hendrick; Martin Teall; Duncan Hannah; Sarah Almond; Nicola Brice; Anthony H Dickenson Journal: J Pharmacol Exp Ther Date: 2014-01-28 Impact factor: 4.030
Authors: Jae Sik Nam; Yu Seon Cheong; Myong Hwan Karm; Ho Soo Ahn; Ji Hoon Sim; Jin Sun Kim; Seong Soo Choi; Jeong Gil Leem Journal: Korean J Pain Date: 2014-10-01
Authors: V Blair Journigan; Zhiwei Feng; Saifur Rahman; Yuanqiang Wang; A R M Ruhul Amin; Colleen E Heffner; Nicholas Bachtel; Siyi Wang; Sara Gonzalez-Rodriguez; Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Jacob K Hilton; Wade D Van Horn; Antonio Ferrer-Montiel; Xiang-Qun Xie; Taufiq Rahman Journal: ACS Chem Neurosci Date: 2020-01-09 Impact factor: 4.418
Authors: Carmen De Caro; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Antonio Calignano; Andrea Aramini; Gianluca Bianchini; Marcello Allegretti; Laura Brandolini Journal: Br J Pharmacol Date: 2018-04-14 Impact factor: 8.739
Authors: Carmen De Caro; Claudia Cristiano; Carmen Avagliano; Alessia Bertamino; Carmine Ostacolo; Pietro Campiglia; Isabel Gomez-Monterrey; Giovanna La Rana; Oreste Gualillo; Antonio Calignano; Roberto Russo Journal: Int J Mol Sci Date: 2019-11-07 Impact factor: 5.923
Authors: Mariana A Freitas; Amanda Vasconcelos; Elaine C D Gonçalves; Eduarda G Ferrarini; Gabriela B Vieira; Donatella Cicia; Maíra Cola; Raffaele Capasso; Rafael C Dutra Journal: Biomolecules Date: 2021-04-17